ELOVL7 and neoplasm: In vitro FA elongation assay and FA composition analysis showed that ELOVL-7 is preferentially involved in FA elongation of very-long-chain SFAs included in phospholipids and neutral lipids (i.e., cholesterol ester) and when silenced it reduces androgens synthesis and CRPC tumor growth (51).